262 results about "Paeonia lactiflora" patented technology

The invention relates to the field of traditional Chinese medicine compositions, in particular to a composition for dispelling effects of alcohol and protecting liver and application. The composition for dispelling the effects of alcohol and protecting the liver comprises the following raw materials: 1-4 parts of calculus bovis factitius, 1-4 parts of artificial bear gall, 35-55 parts of a pseudo-ginseng extract, 40-60 parts of a herba artemisiae scopariae extract, 50-70 parts of a rhizoma smilacis glabrae extract, 30-50 parts of a polygonum cuspidatum extract, 30-50 parts of a radix paeoniae alba extract, 70-90 parts of a pueraria flower extract, 40-60 parts of a rhizoma polygonati extract and 40-60 parts of a dark malt extract. And 25-35 parts of a fructus amomi extract. The hangover-alleviating and liver-protecting composition has the advantages that the hangover-alleviating and liver-protecting effects are similar to that of a positive medicine Haiwang Jinvessel for relieving rat body mass reduction caused by an acute drunkenness model, the hangover-alleviating rate within 6 hours and the liver-protecting and anti-oxidation effects are similar to that of a positive medicine Haiwang Jinvessel, the body mass improvement effect, the hangover-alleviating rate and the anti-oxidation capability of a body are better, and the hangover-alleviating and liver-protecting composition has good development and application values.

The invention provides a traditional Chinese medicine composition for treating early primary Parkinson's disease and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 2-5 parts of radix astragali, 2-5 parts of radix asparagi, 4-6 parts of radix polygonati officinalis, 1-3 parts of fructus gardeniae, 1-3 parts of fermented soybean, 2-5 parts of fructus trichosanthis, 1-3 parts of radix curcumae, 2-5 parts of radix angelicae sinensis, 1-3 parts of rhizoma chuanxiong, 5-7 parts of radix paeoniae alba, 2-5 parts of caulis spatholobi, 1-3 parts of semen persicae, 1-3 parts of semen armeniacae amarae, 2-5 parts of fructus cannabis, 3-5 parts of radix asteris and 1-3 parts of radix platycodonis. And 15-20 parts by weight of an auxiliary material. The invention also provides a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition provided by the invention can realize a treatment effect on the early primary Parkinson's disease.

The invention belongs to the technical field of cosmetics, and particularly relates to a composition with a moisturizing effect and a preparation method and application thereof. The composition comprises the following components in percentage by weight: 0.3%-0.8% of a plant fermentation product, 1.2%-2.0% of a plant enzymolysis product, 15%-20% of a humectant, 1.6%-2.5% of a chondrus crispus extract, 0.5%-1.1% of a Chinese herbaceous peony extract, 2.6%-3.9% of a rosemary extract and the balance of water. The composition is suitable for people with allergic reaction caused by face dryness, has a good moisturizing effect, has a long-acting moisturizing effect, also has repairing and anti-aging effects, is mild and non-irritant, and can be used for preparing face moisturizing products.

The present invention discloses a pharmaceutical composition for preventing and / or treating breast cancer, and its preparation method and use. The pharmaceutical composition is prepared from components including the following raw materials: 6-11 parts by weight of Cyperus rotundus, 5-11 parts by weight of Bolbostemma paniculatum, 12-16 parts by weight of Fritillaria thunbergii, 6-16 parts by weight of Paeonia lactiflora, 9-31 parts by weight of Astragalus membranaceus, 6-13 parts by weight of Ligustrum lucidum, 6-11 parts by weight of Epimedium brevicornu, 3-6 parts by weight of Olibanum, 3-6 parts by weight of Myrrha, 12-15 parts of Psoralea corylifolia and 0.9-1.3 parts by weight of Momordica cochinchinensis. The pharmaceutical composition of the present invention can prevent and / or treat breast cancer, and has fewer types of raw materials.

The present invention relates to a traditional Chinese medicine composition for treating psoriasis, and its preparation method and use. The traditional Chinese medicine composition is prepared from the following raw materials: Portulaca oleracea, Sophora flavescens, Dictamni bark, Honeysuckle, Kochia scoparia, Phellodendron amurense, Platycladus orientalis leaves, Paeonia lactiflora, and Lithospermum officinale. The traditional Chinese medicine composition of the present invention has a scientific and reasonable formulation, synergistic efficacy, a small number of ingredients, and controlled quality. The combination of monarch, minister, adjuvant, and envoy in the present invention's formulation is scientific and reasonable. The combination of anti-inflammatory and immunomodulatory heat-clearing, blood-cooling, and antipruritic drugs can effectively eliminate the cause of the disease and enhance the antipruritic effect, exerting anti-inflammatory, antiproliferative, and local vasoconstrictive effects, with the advantages of increased efficacy and reduced toxicity, and can reduce the risk of recurrence. This promotes epithelial tissue repair, maintains the dynamic balance of skin keratinization, effectively prevents the recurrence of psoriasis, and reduces the suffering of patients.

The invention discloses a freckle-removing mask preparation method and equipment, and relates to the technical field of beauty and skincare, the freckle-removing mask preparation method comprises the following steps: S1, selecting and purchasing: selecting and purchasing high-quality formula raw materials; s2, inspection: inspecting the purchased raw materials; s3, pretreatment: washing part of the Chinese herbal medicine raw materials with clear water, and drying the Chinese herbal medicine raw materials; s4, pre-processing: crushing and grinding the prepared raw materials, and screening and filtering to remove impurities; the facial mask is prepared from ligusticum, radix angelicae, radix asparagi, astragalus membranaceus, bighead atractylodes rhizome, silkworm larva, bletilla striata, radix paeoniae alba, poria cocos, salvia miltiorrhiza, ampelopsis japonica, tribulus terrestris, pseudo-ginseng, rose, ginseng, honeysuckle, pearl and other blood-activating and repairing components, so that the effect of eliminating laser spots and heavy metal residual spots is improved, and meanwhile, the whitening degree and the skin glossiness are improved; the ductility, the moistening property and the permeability are improved, the stickiness and the greasiness are reduced, the moisturizing and water locking durability is improved through moisturizing factors of various components, and the spot fading effect is improved.

The invention discloses a composition with relieving and itching relieving effects as well as a preparation method and application thereof, and particularly belongs to the field of cosmetics. The composition comprises the following components: a composite plant extract, polyol and water, the composite plant extract is prepared by compounding a rhizoma polygonati fermentation liquid, a Chinese herbaceous peony extract and a caulerpa lentillifera extract; the rhizoma polygonati fermentation liquor is obtained by carrying out compound fermentation on lactobacillus pentosus and bacillus subtilis. The soothing and itching relieving composition provided by the invention has an excellent soothing effect, the soothing and itching relieving composition provided by the invention has an excellent in-vitro hyaluronidase inhibition effect, and the in-vitro hyaluronidase inhibition rate reaches 60% or above.

This invention provides a traditional Chinese medicine composition for the prevention and treatment of knee arthritis. The active ingredients, by weight, include: 15-25 parts of Salvia miltiorrhiza, 8-15 parts of Ligusticum chuanxiong, 12-20 parts of Angelica sinensis, 7-15 parts of Lycopus lucidus, 15-30 parts of Poria cocos, 8-15 parts of Placenta hominis, 18-30 parts of Clematis chinensis, 15-25 parts of Spatholobus suberectus, 25-40 parts of Paeonia lactiflora, 12-20 parts of Rehmannia glutinosa, and 8-15 parts of Glycyrrhiza uralensis. Using Salvia miltiorrhiza, Ligusticum chuanxiong, Angelica sinensis, Lycopus lucidus, Poria cocos, Placenta hominis, Clematis chinensis, Spatholobus suberectus, Paeonia lactiflora, Rehmannia glutinosa, and Glycyrrhiza uralensis as raw materials, this invention follows the principle of "principal, assistant, adjuvant, and guide" in traditional Chinese medicine. The combined use of these herbs can tonify the liver and kidneys, promote blood circulation and remove blood stasis, and has a good therapeutic effect on knee arthritis caused by liver and kidney deficiency and qi stagnation and blood stasis.

This invention discloses a key miRNA that regulates peony plant height, stem diameter, and xylem formation, and its applications. The precursor and mature sequences of this peony miRNA are shown in SEQ ID NO.1 and SEQ ID NO.2, respectively. The peony miRN82 provided by this invention can be used to regulate peony growth. Overexpression of miRN82 reduces peony plant height and stem diameter, and narrows the xylem width, indicating that miRN82 is a key miRNA regulating peony plant height, stem diameter, and xylem formation. This invention regulates peony plant height, stem diameter, and xylem thickness by overexpressing or knocking out / silencing miRN82, enabling the breeding of peony varieties with different stem heights, thicknesses, and hardnesses according to specific needs. Therefore, it has significant application value in peony molecular breeding.

The invention relates to a traditional Chinese medicine composition for treating Pi-dan disease. The traditional Chinese medicine composition is prepared from the following raw materials: ramulus euonymi, radix trichosanthis, rhizoma polygonati, raw radix astragali, rhizoma polygoni cuspidati, stiff silkworm, radix scrophulariae, endothelium corneum gigeriae galli, radix puerariae, mantis egg-case, radix paeoniae rubra and radix salviae miltiorrhizae. The traditional Chinese medicine composition for treating the Pi-dan disease is convenient to use, definite in curative effect, simple in production process, high in implementation and easy for large-scale industrial development; the traditional Chinese medicine composition is used for treating shortness of breath, weakness, thirst, dizziness and heavy body of a patient suffering from Pi-dan, has a remarkable effect of improving blood sugar indexes, and has important clinical value.

This invention discloses a traditional Chinese medicine composition for reversing type 2 diabetes and its preparation method, belonging to the field of traditional Chinese medicine technology. It comprises the following raw materials in parts by weight: Astragalus membranaceus 25-35 parts, Rehmannia glutinosa 20-30 parts, Trichosanthes kirilowii 15-25 parts, Anemarrhena asphodeloides 10-20 parts, Coptis chinensis 8-15 parts, Salvia miltiorrhiza 15-25 parts, Ligusticum chuanxiong 8-15 parts, Paeonia lactiflora 10-20 parts, Pueraria lobata 20-30 parts, Atractylodes lancea 10-20 parts, Poria cocos 15-25 parts, Alisma plantago-aquatica 10-20 parts, Ophiopogon japonicus 15-25 parts, Schisandra chinensis 5-15 parts, and Glycyrrhiza uralensis 3-10 parts. This invention strictly follows the principles of traditional Chinese medicine's principal, assistant, adjuvant, and guide herb combination, comprehensively addressing the four methods of invigorating qi and nourishing yin, clearing heat, resolving blood stasis, and eliminating turbidity. It regulates the body's metabolism from the root cause, significantly controlling blood sugar and improving insulin resistance, while also protecting pancreatic function, thus solving the problems of single herb combinations and limited efficacy in traditional Chinese medicine.

The invention discloses a traditional Chinese medicine composition for preventing and treating light and moderate varicocele and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 12 to 30 parts of radix paeoniae rubra, 9 to 24 parts of peach kernel, 9 to 24 parts of spina gleditsiae, 9 to 24 parts of radix cyathulae, 6 to 18 parts of cassia twig, 9 to 24 parts of fructus forsythiae, 6 to 18 parts of thunberg fritillary bulb, 6 to 18 parts of rhodiola rosea, 6 to 18 parts of semen aesculi and 3 to 15 parts of raw liquorice. After the traditional Chinese medicine composition provided by the invention is adopted for treatment, the spermatovenous reflux time is remarkably shortened, the semen quality including semen volume, sperm density and sperm motility is remarkably improved, the total effective rate of treatment is higher than that of other prescriptions, the living quality of a patient is remarkably improved, the medicine safety is high, and the varicocele can be effectively treated.

This invention provides a traditional Chinese medicine composition, preparation method, and application for treating frequent urination with incontinence in various postmenopausal symptoms. The traditional Chinese medicine composition, by weight, consists of the following raw materials: Astragalus membranaceus 10-20 parts, Codonopsis pilosula 10-15 parts, Atractylodes macrocephala 7.5-10 parts, Ziziphus jujuba var. spinosa 10-15 parts, Mantis religiosa ootheca 4-5 parts, Paeonia lactiflora 7.5-15 parts, Rehmannia glutinosa 6-10 parts, Angelica sinensis 7.5-10 parts, Cinnamomum cassia 1.5-2.5 parts, Poria cocos 6-7.5 parts, Lindera strychnifolia 5-6 parts, Schisandra chinensis 5-6 parts, Psoralea corylifolia 4-6 parts, Alpinia oxyphylla 4-6 parts, Citrus reticulata 4-6 parts, Polygala tenuifolia 3-4 parts, Cane sucrose (peeled) 10-30 parts, Zingiber officinale (peeled) 5-7.5 parts, Ziziphus jujuba 5-7.5 parts, and Glycyrrhiza uralensis (processed) 3-4 parts. The traditional Chinese medicine composition of the present invention has definite curative effect, is safe to use, and has no obvious toxic side effects.

This invention discloses a traditional Chinese medicine composition for treating senile pruritus and its preparation method. The composition consists of the following raw materials in parts by weight: Angelica sinensis 15-25 parts, Astragalus membranaceus 12-20 parts, Paeonia lactiflora 10-18 parts, Saposhnikovia divaricata 8-15 parts, Dictamnus dasycarpus 6-12 parts, Kochia scoparia 6-12 parts, Schizonepeta tenuifolia 6-10 parts, Ligusticum chuanxiong 5-10 parts, Ophiopogon japonicus 4-8 parts, and Glycyrrhiza uralensis 3-6 parts. The preparation method includes: raw material pretreatment, water extraction, alcohol extraction, consolidation and concentration, and optional addition of excipients to prepare a bath liquid or powder. This invention is based on the pathogenesis of "deficiency of Qi and blood, blood deficiency and wind dryness," using Angelica sinensis and Astragalus membranaceus as the principal herbs to invigorate Qi and nourish blood to strengthen the body's foundation, and using adjuvant herbs to dispel wind and moisten dryness to treat the symptoms, achieving both symptomatic and root-cause treatment. Comparative experiments have shown that this invention produces unexpected synergistic effects in terms of barrier repair, antipruritic effect, and extraction rate. This invention has a standardized process, is easy to use, and is suitable for widespread application.

The present invention relates to the field of traditional Chinese medicine, and specifically provides a traditional Chinese medicine composition, a pharmaceutical preparation, and their preparation methods and uses. It is obtained by repeatedly optimizing the composition and content of the traditional Chinese medicine compound through clinical research and basic research. In the formula, Coptis chinensis is used as the monarch drug; Rheum palmatum, Anemarrhena asphodeloides, and Paeonia lactiflora are used as the ministerial drugs; Aurantium reticulatum and Monascus purpureus are used as adjuvant drugs; and Zingiber officinale is used as the guiding drug to reduce the cold nature of various drugs. When all the drugs are combined, none can be missing, and they work together to clear heat and lower turbidity, and reduce blood sugar and weight, having an obvious therapeutic effect on obesity, the inducement of diabetes, and diabetic patients (especially early-stage "hot-state" patients), and significantly improving the therapeutic effect on diabetes.

This invention discloses a Zhishu Yangwei tablet for chronic gastritis and its granule dry-compression tableting process, relating to the field of traditional Chinese medicine preparation technology. The Yangwei tablet is made from the following raw materials in parts by weight: Codonopsis pilosula 35-45 parts, stir-fried Atractylodes macrocephala 18-22 parts, Poria cocos 18-22 parts, Glycyrrhiza uralensis 8-12 parts, Amomum villosum 18-22 parts, Lindera strychnifolia 18-22 parts, Salvia miltiorrhiza 45-55 parts, roasted Aucklandia lappa 18-22 parts, Paeonia lactiflora 18-22 parts, stir-fried Citrus aurantium 18-22 parts, Magnolia officinalis 28-32 parts, Lilium brownii 35-45 parts, and stir-fried chicken gizzard lining 18- 22 parts, dried plum 45-55 parts, Coptis chinensis 8-12 parts, hawthorn 35-45 parts, magnesium stearate 5-7 parts, sucrose 28-32 parts; This invention uses low-temperature dynamic extraction technology to replace the traditional high-temperature decoction process, effectively reducing the decomposition loss of heat-sensitive active ingredients such as tanshinone IIA and ursolic acid, and improving the bioavailability of the drug. It also uses membrane concentration and spray drying technology to replace the traditional atmospheric pressure concentration and oven drying process, shortening the production cycle, reducing energy consumption, and avoiding the degradation of active ingredients caused by prolonged heating of materials.

This invention relates to the field of external moxibustion devices in traditional Chinese medicine, and in particular to a moxa stick for clearing dampness using the thunder-fire method, and its preparation method. The moxa stick comprises moxa wool, compound Chinese herbal powder, and moxa leaf paper; the compound Chinese herbal powder includes principal, assistant, adjuvant, and guiding herbs; the principal herbs include Evodia rutaecarpa, Cinnamomum cassia, and Ligusticum chuanxiong; the assistant herbs include stir-fried Atractylodes lancea, Poria cocos, Polyporus umbellatus, Alisma plantago-aquatica, stir-fried Atractylodes macrocephala, Astragalus membranaceus, and Amomum villosum; the adjuvant herbs include stir-fried Phellodendron chinense, Sophora flavescens, Artemisia capillaris, Gardenia jasminoides, Akebia quinata, Pinellia ternata, Centella asiatica, and Rosa laevigata root; the guiding herbs include Angelica dahurica, Pogostemon cablin, Angelica sinensis, Paeonia lactiflora, Glycyrrhiza uralensis, and Nelumbo nucifera leaf. This invention, guided by compound formulation theory, material innovation, process optimization, and packaging design, provides a thunder-fire moxa stick with strong targeted dampness-clearing properties, stable combustion performance, safety, portability, and controllable quality, showing promising application prospects.

This invention proposes a traditional Chinese medicine preparation and its preparation method for treating olfactory dysfunction in Parkinson's disease of the liver and kidney yin deficiency type. Belonging to the field of traditional Chinese medicine preparations, it is made from the following raw materials: 10-15g of Rehmannia glutinosa (processed), 20-30g of Paeonia lactiflora, 10-15g of Spatholobus suberectus, 12-15g of Eclipta prostrata, 10-15g of Ligustrum lucidum, 8-10g of Centipeda minima, 10-15g of Acorus tatarinowii, and 10-15g of Angelica dahurica. The entire formula works synergistically to nourish the liver and kidneys, invigorate blood circulation, and clear the nasal passages, exhibiting good clinical therapeutic effects. This invention assesses the olfactory function of patients with olfactory dysfunction in Parkinson's disease of the liver and kidney yin deficiency type using the T&T olfactory test and other methods, and applies a traditional Chinese medicine nasal spray treatment, systematically exploring the therapeutic efficacy of this external application of traditional Chinese medicine for the aforementioned symptoms. This invention can provide clinical data support for the standardized diagnosis and treatment of olfactory dysfunction in Parkinson's disease and has significant clinical application value for improving patients' quality of life and optimizing the prognostic assessment system.

The invention relates to the technical field of traditional Chinese medicine preparations, and provides a traditional Chinese medicine composition with acid inhibiting and esophagus protecting effects, which is prepared by compatibility of the following raw material medicines in parts by weight: 6-12 parts of coptis chinensis; 2 to 6 parts of fructus evodiae; 15 to 25 parts of cuttlebone; 10 to 20 parts of inula flower; 15 to 25 parts of ruddle; 12-20 parts of radix paeoniae alba; 8-15 parts of dried orange peel; and 6-10 parts of licorice root. According to the traditional Chinese medicine composition disclosed by the invention, through synergistic compatibility of multiple raw material medicines, the comprehensive efficacy of inhibiting acid, protecting mucous membranes and regulating power is realized, related symptoms are mildly relieved, no adverse reaction exists, and the traditional Chinese medicine composition is suitable for long-term conditioning. The standardized preparation process improves the extraction rate of effective components, ensures the stable and consistent curative effect of the product, overcomes the problems of extensive process and unstable quality of the traditional Chinese medicine preparation, and is suitable for different people, convenient to take, high in compliance, easily available in raw materials, controllable in cost and suitable for industrial production and clinical popularization.

The invention provides an application of a traditional Chinese medicine composition in preparing a medicine for preventing hepatic fibrosis. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 128 to 137 parts of radix scutellariae, 128 to 137 parts of radix bupleuri, 103 to 120 parts of radix et rhizoma rhei, 128 to 137 parts of fructus aurantii, 128 to 137 parts of herba artemisiae scopariae, 171 to 200 parts of rhizoma polygoni cuspidati, 137 to 150 parts of fructus gardeniae, 250 to 342 parts of herba lysimachiae, 128 to 137 parts of radix paeoniae alba, 128 to 137 parts of radix aucklandiae, 90 to 103 parts of rhizoma pinelliae preparata and 34 to 40 parts of rhizoma zingiberis recens. The traditional Chinese medicine composition can obviously reduce the expression level of alpha-SMA and TGF-beta in the liver and relieve the occurrence of hepatic fibrosis, and can be used for preventing hepatic fibrosis.

The invention discloses a moisturizing and soothing fermentation composition as well as a preparation method and application thereof. The preparation method of the moisturizing and soothing fermentation composition comprises the following steps: (1) inoculating a fermentation substrate containing centella asiatica and paeonia lactiflora with a seed solution of hirsutella asiatica for fermentation so as to obtain a crude fermentation solution; and (2) carrying out heating treatment and filtering treatment on the crude fermentation liquid to obtain the moisturizing and soothing fermentation composition. The moisturizing and soothing fermentation composition prepared by the invention adopts a mode of extracting and preparing multiple components at the same time, a galactose yeast-like bacterium fermentation product filtrate is prepared, and the moisturizing and soothing fermentation composition also contains a centella asiatica extract and a Chinese herbaceous peony extract; the composition can promote the expression of a paphiopedilum A protein gene, reduce the expression of an IL-6 gene and inhibit zebra fish neutrophile granulocyte aggregation; the moisturizing and soothing effects can be shown from multiple angles.

The invention belongs to the field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition and a preparation and application thereof. A compatibility system of monarch, minister, assistant and guide is adopted, rhizoma atractylodis, semen coicis and cortex phellodendri are taken as monarch drugs, polygonum cuspidatum, centella asiatica and fructus kochiae are taken as minister drugs, prepared rheum officinale, radix achyranthis bidentatae and caulis spatholobi are taken as guide drugs, gynostemma pentaphyllum, radix paeoniae alba and rhizoma polygonati are taken as adjuvant drugs, the medicinal materials are compounded according to a specific mass ratio, and the mass ratio of the monarch drugs to the minister drugs to the adjuvant drugs to the guide drugs is (50-80): (50-80): (30-55): (35-70). The traditional Chinese medicine composition provided by the invention can remarkably reduce the levels of blood uric acid, serum creatinine and urea nitrogen, reduce urine protein excretion and improve inflammation, a hypercoagulation state and lipid metabolism disorder, the total effective rate reaches 90%, the adverse reaction is slight, and the recurrence rate is low.

This invention discloses a traditional Chinese medicine formula for preventing and treating feline urinary tract diseases, its preparation method, and its application. The formula consists of the following components in parts by weight: 15-25 parts of Psoralea corylifolia, 15-25 parts of Alpinia oxyphylla, 10-20 parts of Trigonella foenum-graecum, 5-15 parts of Zea mays, 5-15 parts of Juncus effusus, 10-20 parts of Dioscorea hypoglauca, 10-20 parts of Phellodendron chinense, 10-20 parts of Lonicera japonica, 5-15 parts of Paeonia lactiflora, and 5-15 parts of Glycyrrhiza uralensis. The traditional Chinese medicine formula provided by this invention has diuretic and urinary tract mucosal repairing effects. It can effectively relieve symptoms such as urinary stones, painful urination, hematuria, or gravel in the urine caused by damp-heat in the lower abdomen. It promotes the repair of the urinary tract mucosa in animals with urinary tract diseases, alleviates inflammatory responses, and prevents the formation of crystals in the urine.

This invention relates to a traditional Chinese medicine preparation for treating infectious bursal disease (IBD), its preparation method, and its application. The preparation comprises the following components: Astragalus membranaceus 45-50 parts, Rehmannia glutinosa 30-45 parts, Isatis indigotica 25-30 parts, Isatis tinctoria 25-30 parts, Gypsum fibrosum 10-45 parts, Lonicera japonica 10-20 parts, Forsythia suspensa 10-30 parts, Taraxacum mongolicum 10-20 parts, Atractylodes macrocephala 15-20 parts, Paeonia lactiflora 15-30 parts, Lilium brownii 15 parts, Anemarrhena asphodeloides 15 parts, and Glycyrrhiza uralensis 10-30 parts. The preparation is achieved through extraction and concentration processes and is effective in treating IBD in chickens caused by both traditional infectious bursal disease virus (IBDV) and novel variant infectious bursal disease virus (nvvIBDV). This medicine significantly improves the cure rate against both traditional and variant strains, showing a particularly significant advantage in treating variant strains.

This invention relates to a highly effective pain-relieving pharmaceutical composition, comprising, by weight, 10-30 parts of Angelica sinensis, 10-30 parts of Chaenomeles speciosa, 10-30 parts of Paeonia lactiflora, 10-30 parts of Boswellia carterii, 10-30 parts of Eupolyphaga sinensis, 5-20 parts of Sappanwood, 5-20 parts of Carthamus tinctorius, 0.1-5 parts of Dracaena cochinchinensis, 5-20 parts of Syzygium aromaticum, 20-40 parts of Hibiscus mutabilis leaf, 20-40 parts of Citrus aurantium, 10-25 parts of Commiphora myrrha, and 20-40 parts of calcined natural copper. The pharmaceutical composition of this invention has advantages such as rapid onset of action, high therapeutic efficacy (≥96%), high significant efficacy (≥65%), low recurrence rate, prolonged recurrence interval, safety and effectiveness, and good patient compliance.

The invention relates to the field of blood-enriching oral liquid, in particular to Zhenqi blood-enriching oral liquid. Sheep placentas, pearls, red ginseng, Chinese wolfberry fruits, astragalus membranaceus, radix angelicae, coix seeds, fresh ginger, Chinese dates, black beans, angelica sinensis, radix puerariae and Chinese herbaceous peony are used as functional component raw materials. The sheep placenta is hydrolyzed by pancreatin to obtain hydrolysate rich in protein, polypeptide, amino acid, collagen, female progestational hormone and the like, and the palatability of the oral liquid is improved through deodorization and decoloration treatment of activated carbon. Neutral protease is firstly added into pearls for enzymolysis, then hydrochloric acid is added for hydrolysis, and protein is converted into a water-soluble component with smaller molecular weight. The pearl hydrolysate is good in water solubility, high in absorptivity and rich in active substances. Soybean isoflavone contained in the black beans is similar to estrogen secreted by a human body in structure. Paeonia lactiflora has the functions of dredging channels and promoting blood circulation. And the other nine blood-enriching traditional Chinese medicines are mutually coordinated to achieve the purposes of nourishing yin and blood, enriching blood and soothing nerves. Qi and blood are effectively regulated, and hypomenorrhea and thin menstruation are treated.

The invention discloses a paeonia lactiflora divided seedling root system moisturizing cup, and relates to the field of plant transplanting. A Chinese herbaceous peony divided seedling root system moisturizing cup comprises a base and further comprises a cup body detachably connected to the base. The U-shaped frame is connected to the base; the arc-shaped clamping plates are symmetrically arranged above the cup body and are assembled on the U-shaped frame in a sliding connection manner; the second air bag is arranged on the inner side of the arc-shaped clamping plate; branches are flexibly wrapped through self-adaptive deformation of the second air bags, damage caused by direct contact of the arc-shaped clamping plates is avoided, and the integrity of the branches is protected to improve the transplanting survival rate; branch gathering leaves are close to each other, the air contact area is reduced, a microenvironment is formed, water evaporation is inhibited to maintain plant vigor, the survival rate of peony plant division seedlings in the transportation process is increased, the second air bag compensates and buffers inertial impact through pressure difference in the transportation process, branches are prevented from being excessively bent, and the survival rate of the plant division seedlings is increased.

The invention belongs to the technical field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating rheumatoid arthritis. The traditional Chinese medicine composition for treating rheumatoid arthritis comprises an aqueous extract, an alcohol extract and a supercritical extract, the aqueous extract is an aqueous extract of Radix Astragali, white peony root and red sage root; the alcohol extracts are alcohol extracts of tripterygium wilfordii, caulis sinomenii and turmeric; the supercritical extract is a supercritical CO2 extract of radix clematidis and zaocys dhumnade. The traditional Chinese medicine composition further comprises a functional component, and the functional component is composed of 2-methyl-5-nitroimidazole and 3-demethylated colchicine. Water extraction, alcohol extraction and supercritical CO2 extraction technologies are comprehensively applied, functional components are introduced, and the ratio of the functional components to traditional Chinese medicine extracts and a preparation process are optimized, so that the treatment effect of the medicine is further enhanced, and a new choice is provided for treatment of rheumatoid arthritis.

Aiming at etiology and pathogenesis of chronic diarrhea caused by deficiency-cold in spleen and stomach, the traditional Chinese medicine composition takes hairyvein agrimony, rhizoma acori graminei and rhizoma atractylodis as monarch drugs and takes dried ginger, fructus psoraleae, schisandra chinensis, myristica fragrans, cinnamon, agastache rugosus and Chinese yam as ministerial drugs; according to the traditional Chinese medicine composition, rhizoma corydalis, radix paeoniae alba, scorched hawthorn fruit, pericarpium granati, plantain herb, red halloysite, fructus chebulae and radix saposhnikoviae are taken as adjuvant drugs, liquorice is taken as a conductant drug, all the drugs are compatible, the purposes of invigorating spleen, replenishing qi, eliminating dampness, promoting diuresis, supporting healthy qi and smoothing middle-jiao qi movement can be achieved, the purpose of stopping diarrhea can be achieved, and the chronic diarrhea caused by deficiency-cold in the spleen and the stomach can be effectively treated.

A traditional Chinese medicine composition for inhibiting or reducing breast cancer cells comprises Euphorbia kansui, Paeonia lactiflora, Glycyrrhiza uralensis, Taraxacum mongolicum, Gardenia jasminoides, and Hordeum vulgare. The weight ratio of Euphorbia kansui, Paeonia lactiflora, Glycyrrhiza uralensis, Taraxacum mongolicum, Gardenia jasminoides, and Hordeum vulgare in the traditional Chinese medicine composition is 1-2:4-6:2-3:3-5:2-4:2-3. This traditional Chinese medicine composition is intended for the preparation of anticancer drugs. The composition is administered to breast cancer cells at an effective dose between 0.1 and 10 mg / ml for culturing. Cell experiments have confirmed that the traditional Chinese medicine composition exhibits inhibitory activity against breast cancer cells, thereby achieving the purpose of treating breast cancer symptoms or inhibiting breast cancer cell activity.